| A1AT | Alpha 1 anti-trypsin |
| A1ATD | Alpha 1 anti-trypsin deficiency |
| AAV | Adeno-associated virus |
| AAVS1 | Adeno-associated virus integration site 1 |
| ABCA1 | ATP-binding cassette subfamily A member 1 |
| AdV | Adenovirus |
| AGT | Alanine:glyoxylate aminotransferase |
| AIP | Acute intermittent porphyria |
| ALT | Alanina aminotrasferasa |
| BBB | Blood brain barrier |
| BCNU | Bis-cloroethyl-nitrosourea |
| BM | Bone marrow |
| CAR | Coxsackie and adenovirus receptor |
| CAV-2 | Canine adenoviral vector type 2 |
| CF | Cystic fibrosis |
| CFTR | Cystic fibrosis transmembrane conductance regulator |
| ChAdV | Chimpanzee adenovirus |
| CNS | Central nervous system |
| CPS1D | Carbamoyl phosphate synthetase 1 deficiency |
| CR1 | complement receptor 1 |
| CRISPR/Cas | Clustered regularly interspaced short palindromic repeats-associated protein 9 |
| DC | Dendritic cells |
| DMD | Duchenne muscular dystrophy |
| EBNA-1 | Epstein-Barr nuclear antigen 1 |
| EBV | Epstein-Barr virus |
| EF1α | Elongation factor 1 alpha |
| Epo | Erythropoietin |
| ESC | Embryonic stem cells |
| FGAdV | First-generation adenoviral vector |
| FLP | Flippase |
| Flt3L | FMS-like tyrosine kinase 2 ligand |
| FRT | Flippase recognition target |
| GAA | Acid alpha-glucosidase |
| GMP | Good manufacturing practices |
| HAdV | Human adenovirus |
| HBsAg HBV |
Hepatitis B virus small surface antigen Hepatitis B virus |
| HC-AdV | High-Capacity adenoviral vector |
| HCV | Hepatitis C virus |
| HD-AdV | Helper-Dependent adenoviral vector |
| HDL | High-density lipoprotein |
| hmNPC | Human midbrain neuroprogenitor cells |
| HR | Homologous recombination |
| HSC | Hematopoietic stem cells |
| HSPG | Heparan sulphate proteoglycans |
| HSV | Herpes simplex virus |
| HV | Helper virus |
| HVR5 | Hypervariable region V |
| IFN | Interferon |
| IgM | Immunoglobulin M |
| IL-6 | Interleukin 6 |
| iPSC | Induced pluripotent stem cells |
| ITR | Inverted terminal repeats |
| iu | Infection units |
| LDL | Low density lipoprotein |
| LDLR | Low density lipoprotein receptor |
| LRRK2 | Leucine-rich repeat kinase 2 |
| LSD MERS-CoV |
Lysosomal storage disorders Middle East respiratory syndrome coronavirus |
| MHCI | Major histocompatibility complex class I |
| MOI | Multiplicity of infeciton |
| MPSVII | Mucopolysaccharidosis type VII |
| MSP-1 | Merozoite surface protein 1 |
| NAb | Neutralizing antibody |
| NHP | Non-human primates |
| OAV | Oncolytic adenovirus |
| PBGD | Porphobilinogen deaminase |
| PEI | Polyethylene glycol |
| PEPCK | Phosphoenolpyruvate carboxykinase |
| pfu | Plaque forming units |
| PH1 | Primary hyperoxaluria type 1 |
| PRR | Pattern recognition receptor |
| pTP | Pre-terminal protein |
| SAdV SARS-CoV-2 |
Simian adenovirus Severe acute respiratory syndrome coronavirus 2 |
| SB | Sleeping beauty |
| TALEN | Transcription activator-like effector nucleases |
| TARGT | Transduced autologous restorative gene therapy |
| TLR | Toll-like receptor |
| TNFα | Tumor necrosis factor alpha |
| TP | Terminal protein |
| TRIO | Tracing the relationship of inputs and outputs |
| UGT1A1 | Uridine diphospho-glucuronyl transferase 1A1 |
| vg | viral genomes |
| VLDL | Very low density lipoprotein |
| vp | viral particles |
| ZFN | Zinc Finger Nucleases |